BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22799338)

  • 1. Antitumor activity of histone deacetylase inhibitor trichostatin A in osteosarcoma cells.
    Cheng DD; Yang QC; Zhang ZC; Yang CX; Liu YW
    Asian Pac J Cancer Prev; 2012; 13(4):1395-9. PubMed ID: 22799338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
    Duo J; Ma Y; Wang G; Han X; Zhang C
    DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone Deacetylase Inhibitor Trichostatin a Promotes the Apoptosis of Osteosarcoma Cells through p53 Signaling Pathway Activation.
    Deng Z; Liu X; Jin J; Xu H; Gao Q; Wang Y; Zhao J
    Int J Biol Sci; 2016; 12(11):1298-1308. PubMed ID: 27877082
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells.
    Chiba T; Yokosuka O; Fukai K; Kojima H; Tada M; Arai M; Imazeki F; Saisho H
    Oncology; 2004; 66(6):481-91. PubMed ID: 15452378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways.
    Hrgovic I; Doll M; Kleemann J; Wang XF; Zoeller N; Pinter A; Kippenberger S; Kaufmann R; Meissner M
    BMC Cancer; 2016 Sep; 16(1):763. PubMed ID: 27716272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term stimulation with histone deacetylase inhibitor trichostatin a induces epithelial-mesenchymal transition in nasopharyngeal carcinoma cells without increasing cell invasion ability.
    Shen Z; Liao X; Shao Z; Feng M; Yuan J; Wang S; Gan S; Ha Y; He Z; Jie W
    BMC Cancer; 2019 Mar; 19(1):262. PubMed ID: 30902084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone Deacetylase Inhibitor Trichostatin A Suppresses Cell Proliferation and Induces Apoptosis by Regulating the PI3K/AKT Signalling Pathway in Gastric Cancer Cells.
    An X; Wei Z; Ran B; Tian H; Gu H; Liu Y; Cui H; Zhu S
    Anticancer Agents Med Chem; 2020; 20(17):2114-2124. PubMed ID: 32593284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors repress chondrosarcoma cell proliferation.
    Zhu J; Gu J; Ma J; Xu Z; Tao H
    J BUON; 2015; 20(1):269-74. PubMed ID: 25778327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The histone deacetylase inhibitor, Trichostatin A, induces G2/M phase arrest and apoptosis in YD-10B oral squamous carcinoma cells.
    Anh TD; Ahn MY; Kim SA; Yoon JH; Ahn SG
    Oncol Rep; 2012 Feb; 27(2):455-60. PubMed ID: 21993600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of histone deacetylase on prostate carcinoma.
    Zhang Y; Xu Q; Liu G; Huang H; Lin W; Huang Y; Chi Z; Chen S; Lan K; Lin J; Zhang Y
    Int J Clin Exp Pathol; 2015; 8(11):15030-4. PubMed ID: 26823840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of histone deacetylase inhibitor Trichostatin A induced apoptosis in human osteosarcoma cells.
    Roh MS; Kim CW; Park BS; Kim GC; Jeong JH; Kwon HC; Suh DJ; Cho KH; Yee SB; Yoo YH
    Apoptosis; 2004 Sep; 9(5):583-9. PubMed ID: 15314286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone Deacetylase Inhibitors Inhibit the Proliferation of Gallbladder Carcinoma Cells by Suppressing AKT/mTOR Signaling.
    Zhang P; Guo Z; Wu Y; Hu R; Du J; He X; Jiao X; Zhu X
    PLoS One; 2015; 10(8):e0136193. PubMed ID: 26287365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and promotes apoptosis of esophageal squamous cell lines.
    Ma J; Guo X; Zhang S; Liu H; Lu J; Dong Z; Liu K; Ming L
    Mol Med Rep; 2015 Jun; 11(6):4525-31. PubMed ID: 25634603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors suppress the growth of human osteosarcomas in vitro and in vivo.
    Wu Z; Ma C; Shan Z; Ju Y; Li S; Zhao Q
    J BUON; 2013; 18(4):1032-7. PubMed ID: 24344034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of trichostatin A on anti HepG2 liver carcinoma cells: inhibition of HDAC activity and activation of Wnt/β-Catenin signaling.
    Shi QQ; Zuo GW; Feng ZQ; Zhao LC; Luo L; You ZM; Li DY; Xia J; Li J; Chen DL
    Asian Pac J Cancer Prev; 2014; 15(18):7849-55. PubMed ID: 25292076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of trichostatin A and paclitaxel on the proliferation and apoptosis of lung adenocarcinoma cells.
    Zhang S; Zhang QC; Jiang SJ
    Chin Med J (Engl); 2013 Jan; 126(1):129-34. PubMed ID: 23286491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer activities of trichostatin A on maligant lymphoid cells.
    Sun C; Liu X; Chen Y; Liu F
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(5):538-41. PubMed ID: 17219961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of trichostatin A and paclitaxel on the growth and apoptosis of lung adenocarcinoma cell lines].
    Zhang S; Wang XA; Zhang QC; Jiang SJ
    Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):492-6. PubMed ID: 22967465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichostatin A regulates hGCN5 expression and cell cycle on Daudi cells in vitro.
    Liu H; Chen Y; Cui G; Wu G; Wang T; Hu J
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(5):534-7. PubMed ID: 17219960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma.
    Dalgard CL; Van Quill KR; O'Brien JM
    Clin Cancer Res; 2008 May; 14(10):3113-23. PubMed ID: 18483379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.